The researchers discovered that CD4 + Th1 cells, a type of immune cell, play a key role in targeting and eliminating dormant cancer cells. These cells, which can remain hidden in the body, have ...

Th1 cells can mount an anti-cancer response but are short-lived, while Th17 cells have greater longevity but are unable to mount a response. Combining the two harnesses the strengths of both ...

increased regulatory T cells while decreasing inflammatory TH1 and TH17 cells, highlighting MSCs' potential as a novel treatment to prevent ocular complications associated with GVHD. Graft-versus ...

Improper self-antigen recognition by DCs and T-cell initiates, through release of specific cytokines (as described above), destructive Th1 or Th2 responses. RA, for example, is characterized by an ...